STOCK TITAN
  1. Home
  2. Sec-filings
  3. PAYS
  4. [Form 4] Paysign, Inc. Insider Trading Activity

PAYS Form 4: Strobo Exercises 64K RSUs, Sells Portion at $7.09

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Paysign, Inc. (PAYS) – Form 4 insider activity

Chief Legal Officer Robert Strobo reported two transactions. On 31 Jul 2025 he vested/exercised 64,000 restricted shares (Code “M”) at $0, lifting his direct holding to 273,811 shares. On 4 Aug 2025 he sold 26,521 common shares in the open market (Code “S”) at a weighted-average price of $7.0851 (range $6.9976–$7.1530). Post-sale he directly owns 247,290 shares.

The stock grant vests 20 % annually from 31 Jul 2022 through 31 Jul 2027. Derivative table shows 128,000 shares still underlying outstanding awards.

  • Net change: +37,479 shares retained.
  • Portion sold: ≈41 % of newly vested shares.

No earnings, guidance, or other financial disclosures are included.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Mixed signal—sale of 26.5k shares offsets larger zero-cost vesting; limited standalone impact.

The Form 4 shows routine RSU vesting followed by a partial sale, common for tax-liability coverage. Strobo retains 247k shares, increasing his position by 37k net, which suggests continued alignment with shareholders. Sale volume is modest relative to typical daily volume and gives no directional insight into fundamentals. Absent additional insider selling, I view the filing as neutral for valuation and liquidity.

TL;DR: Standard 10b5-1-style disposition; governance risk minimal.

The executive used Code “M” then Code “S”, indicating a structured exercise-and-sell cycle. The disclosure supplies full price ranges and keeps holdings above quarter-million shares, satisfying best-practice transparency. No red flags such as aggressive dumping or derivative hedging appear. Governance impact is considered not material.

Insider Strobo Robert
Role Chief Legal Officer
Sold 26,521 shs ($188K)
Type Security Shares Price Value
Sale Common Stock 26,521 $7.0851 $188K
Exercise Stock Grant 64,000 $0.00 --
Exercise Common Stock 64,000 $0.00 --
Holdings After Transaction: Common Stock — 247,290 shares (Direct); Stock Grant — 128,000 shares (Direct)
Footnotes (1)
  1. One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Strobo Robert
(Last) (First) (Middle)
2615 ST. ROSE PARKWAY
(Street)
HENDERSON NV 89052
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Paysign, Inc. [ PAYS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/31/2025 M 64,000(1) A $0.00 273,811 D
Common Stock 08/04/2025 S(2) 26,521 D $7.0851(2) 247,290 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Grant (1) 07/31/2025 M 64,000 (1) 07/31/2027 Common stock 64,000 $0.00 128,000 D
Explanation of Responses:
1. One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027.
2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Robert Strobo 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR